Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by Funex4ton Aug 11, 2018 8:30pm

86 Views

Post# 28445622

RE:RE:RE:early morning break out

Reading all the news it seems that ONC are setting up for better times. However, the volume of shares trading is low for this to be a certain uptick.

I have only been a shareholder for the last 4 months and would say that the volume needs to increase quite considerably from here to support the expectations.

So where are the investors? Are they all in from the heavy trading that happened at the Toronto to Nasdaq move?

Big price move on Friday but on low volume? Could this be manipulation?

All thoughts gladly read.

cheers

Bullboard Posts

Solar Alliance reports 70% revenue increase